CONCURRENT AGRANULOCYTOSIS AND ACUTE HEPATITIS RESULTING FROM COMBINATION OF CLASSIC NEUROLEPTICS AND SUBSEQUENT SUCCESSFUL CLOZAPINE TREATMENT

被引：6

作者：

BAUER, M ^{[1
]}

机构：

[1] FREE UNIV BERLIN,DEPT PSYCHIAT,W-1000 BERLIN,GERMANY

来源：

PHARMACOPSYCHIATRY | 1995年 / 28卷 / 01期

关键词：

D O I：

10.1055/s-2007-979585

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Agranulocytosis and hepatotoxic reactions are rare but severe side-effects of neuroleptic treatment. This article presents the case of a schizophrenic patient who concurrently developed agranulocytosis and acute hepatic drug reaction as a result of a combination of chemically different neuroleptic drugs. After restoration the patient was successfully treated with clozapine for six months without the hematologic disorders recurring.

引用

收藏

页码：29 / 31

页数：3

相关论文

共 20 条

[1] AGRANULOCYTOSIS INDUCED BY CLOZAPINE WITH THE EARLY ADDITION OF TRIFLUOPERAZINE - A CASE-REPORT [J].

ADAMS, CE ;

RICCIO, M ;

MCCARTHY, D ;

BARNES, TRE ;

HIRSCH, SR .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1990, 5 (04) :287-290

[2]

ALBERTINI RS, 1978, J CLIN PSYCHIAT, V39, P483

[3] CONCURRENT AGRANULOCYTOSIS AND HEPATITIS SECONDARY TO CLOMIPRAMINE THERAPY [J].

ALDERMAN, CP ;

ATCHISON, MM ;

MCNEECE, JI .

BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 :688-689

[4] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].

ALVIR, JMJ ;

LIEBERMAN, JA ;

SAFFERMAN, AZ ;

SCHWIMMER, JL ;

SCHAAF, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167

[5] USUAL AND UNUSUAL AGRANULOCYTOSIS DURING NEUROLEPTIC THERAPY [J].

ANANTH, JV ;

VALLESSJ. ;

WHITELAW, JP .

AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (01) :100-102

[6] TREATMENT OF PSYCHOSIS SUBSEQUENT TO PHENOTHIAZINE-INDUCED AGRANULOCYTOSIS [J].

ANANTH, JV ;

BESZTERCZEY, A .

COMPREHENSIVE PSYCHIATRY, 1973, 14 (04) :319-323

[7] FREQUENCY OF DISTURBANCES OF LIVER-FUNCTION, LEUCOPOESIS, BLOOD-PRESSURE AND TEMPERATURE REGULATION UNDER CLOZAPINE IN COMPARISON WITH PERAZINE AND HALOPERIDOL [J].

BAUER, D ;

GAERTNER, HJ .

PHARMACOPSYCHIATRIA, 1983, 16 (01) :23-29

[8]

BAUER M, 1994, J CLIN PSYCHOPHARM, V14, P71

[9]

CLAAS FHJ, 1989, PSYCHOPHARMACOLOGY, V99, P113

[10]

DUCOMB L, 1977, AM J PSYCHIAT, V134, P1294